208 related articles for article (PubMed ID: 35652923)
1. Insulin-degrading enzyme ablation in mouse pancreatic alpha cells triggers cell proliferation, hyperplasia and glucagon secretion dysregulation.
Merino B; Casanueva-Álvarez E; Quesada I; González-Casimiro CM; Fernández-Díaz CM; Postigo-Casado T; Leissring MA; Kaestner KH; Perdomo G; Cózar-Castellano I
Diabetologia; 2022 Aug; 65(8):1375-1389. PubMed ID: 35652923
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic β-cell-specific deletion of insulin-degrading enzyme leads to dysregulated insulin secretion and β-cell functional immaturity.
Fernández-Díaz CM; Merino B; López-Acosta JF; Cidad P; de la Fuente MA; Lobatón CD; Moreno A; Leissring MA; Perdomo G; Cózar-Castellano I
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E805-E819. PubMed ID: 31479304
[TBL] [Abstract][Full Text] [Related]
3. CART is overexpressed in human type 2 diabetic islets and inhibits glucagon secretion and increases insulin secretion.
Abels M; Riva M; Bennet H; Ahlqvist E; Dyachok O; Nagaraj V; Shcherbina L; Fred RG; Poon W; Sörhede-Winzell M; Fadista J; Lindqvist A; Kask L; Sathanoori R; Dekker-Nitert M; Kuhar MJ; Ahrén B; Wollheim CB; Hansson O; Tengholm A; Fex M; Renström E; Groop L; Lyssenko V; Wierup N
Diabetologia; 2016 Sep; 59(9):1928-37. PubMed ID: 27338624
[TBL] [Abstract][Full Text] [Related]
4. The type 2 diabetes-associated gene ide is required for insulin secretion and suppression of α-synuclein levels in β-cells.
Steneberg P; Bernardo L; Edfalk S; Lundberg L; Backlund F; Ostenson CG; Edlund H
Diabetes; 2013 Jun; 62(6):2004-14. PubMed ID: 23349488
[TBL] [Abstract][Full Text] [Related]
5. Hyperglucagonaemia in diabetes: altered amino acid metabolism triggers mTORC1 activation, which drives glucagon production.
Riahi Y; Kogot-Levin A; Kadosh L; Agranovich B; Malka A; Assa M; Piran R; Avrahami D; Glaser B; Gottlieb E; Jackson F; Cerasi E; Bernal-Mizrachi E; Helman A; Leibowitz G
Diabetologia; 2023 Oct; 66(10):1925-1942. PubMed ID: 37480416
[TBL] [Abstract][Full Text] [Related]
6. Genetic activation of α-cell glucokinase in mice causes enhanced glucose-suppression of glucagon secretion during normal and diabetic states.
Bahl V; Lee May C; Perez A; Glaser B; Kaestner KH
Mol Metab; 2021 Jul; 49():101193. PubMed ID: 33610858
[TBL] [Abstract][Full Text] [Related]
7. Insulin degrading enzyme is up-regulated in pancreatic β cells by insulin treatment.
Fernández-Díaz CM; Escobar-Curbelo L; López-Acosta JF; Lobatón CD; Moreno A; Sanz-Ortega J; Perdomo G; Cózar-Castellano I
Histol Histopathol; 2018 Nov; 33(11):1167-1180. PubMed ID: 29726577
[TBL] [Abstract][Full Text] [Related]
8. Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet.
Kellard JA; Rorsman NJG; Hill TG; Armour SL; van de Bunt M; Rorsman P; Knudsen JG; Briant LJB
Mol Metab; 2020 Oct; 40():101021. PubMed ID: 32446876
[TBL] [Abstract][Full Text] [Related]
9. Dapagliflozin promotes beta cell regeneration by inducing pancreatic endocrine cell phenotype conversion in type 2 diabetic mice.
Wei R; Cui X; Feng J; Gu L; Lang S; Wei T; Yang J; Liu J; Le Y; Wang H; Yang K; Hong T
Metabolism; 2020 Oct; 111():154324. PubMed ID: 32712220
[TBL] [Abstract][Full Text] [Related]
10. Regulation of glucagon secretion by zinc: lessons from the β cell-specific Znt8 knockout mouse model.
Hardy AB; Serino AS; Wijesekara N; Chimienti F; Wheeler MB
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1():112-7. PubMed ID: 21824264
[TBL] [Abstract][Full Text] [Related]
11. On the role of the gut in diabetic hyperglucagonaemia.
Lund A
Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385175
[TBL] [Abstract][Full Text] [Related]
12. Reduced insulin sensitivity and increased β/α cell mass is associated with reduced hepatic insulin-degrading enzyme activity in pregnant rats.
Taschetto APD; Zimath PL; Silvério R; Dos Santos C; Boschero AC; Dos Santos GJ; Rafacho A
Life Sci; 2021 Jul; 277():119509. PubMed ID: 33865877
[TBL] [Abstract][Full Text] [Related]
13. Optimizing reduction in basal hyperglucagonaemia to repair defective glucagon counterregulation in insulin deficiency.
Farhy LS; McCall AL
Diabetes Obes Metab; 2011 Oct; 13 Suppl 1(0 1):133-43. PubMed ID: 21824267
[TBL] [Abstract][Full Text] [Related]
14. Pancreas-specific Gsalpha deficiency has divergent effects on pancreatic alpha- and beta-cell proliferation.
Xie T; Chen M; Weinstein LS
J Endocrinol; 2010 Sep; 206(3):261-9. PubMed ID: 20543009
[TBL] [Abstract][Full Text] [Related]
15. Human islets contain a subpopulation of glucagon-like peptide-1 secreting α cells that is increased in type 2 diabetes.
Campbell SA; Golec DP; Hubert M; Johnson J; Salamon N; Barr A; MacDonald PE; Philippaert K; Light PE
Mol Metab; 2020 Sep; 39():101014. PubMed ID: 32413586
[TBL] [Abstract][Full Text] [Related]
16. Paracrine GABA and insulin regulate pancreatic alpha cell proliferation in a mouse model of type 1 diabetes.
Feng AL; Xiang YY; Gui L; Kaltsidis G; Feng Q; Lu WY
Diabetologia; 2017 Jun; 60(6):1033-1042. PubMed ID: 28280900
[TBL] [Abstract][Full Text] [Related]
17. Autophagy deficiency in β cells blunts incretin-induced suppression of glucagon release from α cells.
Kim MJ; Choi OK; Chae KS; Lee H; Chung SS; Ham DS; Kim JW; Yoon KH; Park KS; Jung HS
Islets; 2015; 7(5):e1129096. PubMed ID: 26744903
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of stearoyl-CoA desaturase 1 in the mouse impairs pancreatic islet morphogenesis and promotes loss of β-cell identity and α-cell expansion in the mature pancreas.
Dobosz AM; Janikiewicz J; Krogulec E; Dziewulska A; Ajduk A; Szpila M; Nieznańska H; Szczepankiewicz AA; Wypych D; Dobrzyn A
Mol Metab; 2023 Jan; 67():101659. PubMed ID: 36529318
[TBL] [Abstract][Full Text] [Related]
19. Anti-diabetic activity of insulin-degrading enzyme inhibitors mediated by multiple hormones.
Maianti JP; McFedries A; Foda ZH; Kleiner RE; Du XQ; Leissring MA; Tang WJ; Charron MJ; Seeliger MA; Saghatelian A; Liu DR
Nature; 2014 Jul; 511(7507):94-8. PubMed ID: 24847884
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of the malate-aspartate shuttle in mouse pancreatic islets abolishes glucagon secretion without affecting insulin secretion.
Stamenkovic JA; Andersson LE; Adriaenssens AE; Bagge A; Sharoyko VV; Gribble F; Reimann F; Wollheim CB; Mulder H; Spégel P
Biochem J; 2015 May; 468(1):49-63. PubMed ID: 25731850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
